Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Quantitative imaging of RAD51 expression as a marker of platinum resistance in ovarian cancer.
EMBO Mol Med. 2021 May 7;13(5):e13366. doi: 10.15252/emmm.202013366. Epub 2021 Mar 11.
EMBO Mol Med. 2021.
PMID: 33709473
Free PMC article.
A multicenter phase II randomized trial of durvalumab (MEDI-4736) versus physician's choice chemotherapy in recurrent ovarian clear cell adenocarcinoma (MOCCA).
Ngoi NY, Heong V, Ow S, Chay WY, Kim HS, Choi CH, Goss G, Goh JC, Tai BC, Lim DG, Kaliaperumal N, Au VB, Connolly JE, Kim JW, Friedlander M, Kim K, Tan DS.
Ngoi NY, et al.
Int J Gynecol Cancer. 2020 Aug;30(8):1239-1242. doi: 10.1136/ijgc-2020-001604. Epub 2020 Jun 25.
Int J Gynecol Cancer. 2020.
PMID: 32591370
Free PMC article.
Clinical Trial.
Item in Clipboard
Clinical potential of boron neutron capture therapy for locally recurrent inoperable previously irradiated head and neck cancer.
Lim D, Quah DS, Leech M, Marignol L.
Lim D, et al.
Appl Radiat Isot. 2015 Dec;106:237-41. doi: 10.1016/j.apradiso.2015.07.044. Epub 2015 Jul 28.
Appl Radiat Isot. 2015.
PMID: 26277052
Review.
Item in Clipboard
Evaluation of the methods to identify patients who may benefit from PARP inhibitor use.
Lim D, Ngeow J.
Lim D, et al.
Endocr Relat Cancer. 2016 Jun;23(6):R267-85. doi: 10.1530/ERC-16-0116. Epub 2016 May 25.
Endocr Relat Cancer. 2016.
PMID: 27226207
Review.
Item in Clipboard
Cite
Cite